Showing results (91-100 of 401) with videos related to
Sort By:
Pageof 41
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 9, 2010
Effects of an alert system on implantable cardioverter defibrillator-related anxiety: rationale, design, and endpoints of the PANORAMIC multicentre trialFirat Duru, Paul Dorian, Stefano Favale, et al.Journal of Cardiac Failure|November 11, 2008
Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failureGordon W Moe, Gabriel Laurent, Liia Doumanovskaia, et al.Pacing and Clinical Electrophysiology : PACE|March 11, 2004
Feasibility of implantable cardioverter defibrillator use in elderly patients: a case series of octogenariansPeter A Noseworthy, Ilan Lashevsky, Paul Dorian, et al.Journal of Cardiovascular Pharmacology|August 2, 2007
The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humansPaul Dorian, Arnold Pinter, Iqwal Mangat, et al.American Heart Journal|March 8, 2017
Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trialVictoria M Robinson, David B Bharucha, Kenneth W Mahaffey, et al.CJC Open|June 7, 2024
ICD Implantation Rates in Cardiac Arrest Survivors in CanadaFarzad Darabi, Nigel S Tan, Katherine S Allan, et al.The Canadian Journal of Cardiology|December 31, 2014
Can diagnostic and procedural skills required to practice cardiology as a specialist be mastered in 3 years?Eric H C Yu, Parvathy Nair, Matthew G Sibbald, et al.Stroke|August 29, 2015
Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation PatientsGregory Y H Lip, Tereza Lanitis, Jack Mardekian, et al.Current Opinion in Cardiology|November 29, 2013
Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapyDavid Fitchett, Atul Verma, John Eikelboom, et al.Health Economics|November 6, 2003
A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities IndexBernie J O'Brien, Marian Spath, Gordon Blackhouse, et al.Pageof 41